PE20171140A1 - Combinacion farmacologica antihiperalgesica, antialodinica y antinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico - Google Patents

Combinacion farmacologica antihiperalgesica, antialodinica y antinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico

Info

Publication number
PE20171140A1
PE20171140A1 PE2017000033A PE2017000033A PE20171140A1 PE 20171140 A1 PE20171140 A1 PE 20171140A1 PE 2017000033 A PE2017000033 A PE 2017000033A PE 2017000033 A PE2017000033 A PE 2017000033A PE 20171140 A1 PE20171140 A1 PE 20171140A1
Authority
PE
Peru
Prior art keywords
treatment
neuropathic pain
pharmaceutical compositions
antialodinic
ant
Prior art date
Application number
PE2017000033A
Other languages
English (en)
Inventor
Armenta Maria Elena Garcia
Ochoa Victor Guillermo Alvarez
Original Assignee
Representaciones E Investig Medicas S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53938368&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20171140(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Representaciones E Investig Medicas S A De C V filed Critical Representaciones E Investig Medicas S A De C V
Publication of PE20171140A1 publication Critical patent/PE20171140A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere a una novedosa combinacion farmaceutica sinergica de un agente antihiperalgesico, antialodinico, analogo del acido gama-aminobutirico (GABA) y un agente antiinflamatorio, en donde el agente antihiperalgesico, antialodinico es Pregabalina, y el agente antiinflamatorio es Meloxicam. La presente invencion ademas esta dirigida a composiciones farmaceuticas que comprenden dicha combinacion. Dichas composiciones son utiles para la prevencion y/o tratamiento del dolor neuropatico ocasionado por diversas etiologias
PE2017000033A 2014-07-07 2015-07-07 Combinacion farmacologica antihiperalgesica, antialodinica y antinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico PE20171140A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014008336A MX2014008336A (es) 2014-07-07 2014-07-07 Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.

Publications (1)

Publication Number Publication Date
PE20171140A1 true PE20171140A1 (es) 2017-08-09

Family

ID=53938368

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2017000033A PE20171140A1 (es) 2014-07-07 2015-07-07 Combinacion farmacologica antihiperalgesica, antialodinica y antinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico

Country Status (5)

Country Link
BR (1) BR112017000359A2 (es)
CO (1) CO2017001076A2 (es)
MX (1) MX2014008336A (es)
PE (1) PE20171140A1 (es)
WO (1) WO2016005897A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019067768A2 (en) 2017-09-28 2019-04-04 Nevakar, Inc. FIXED DOSE COMBINATION FORMULATIONS FOR THE TREATMENT OF PAIN
MX2019008467A (es) * 2019-07-16 2019-11-07 Federico Amezcua Amezcua Combinacion sinergica de s-ketorolaco y pregabalina en una composicion farmaceutica para el tratamiento del dolor neuropatico.
CN112353767A (zh) * 2020-11-16 2021-02-12 海南锦瑞制药有限公司 一种盐酸地尔硫卓和普瑞巴林组合物及其制备方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129907A (en) 1999-08-04 2000-10-10 Colgate Palmolive Company Stable hydrogenated lupulone antibacterial oral compositions
AU2003207219A1 (en) 2002-02-05 2003-09-02 Ajinomoto Co., Inc. Medicinal compositions containing gabapentin or pregabalin and n-type calcium channel antagonist
DE10331305A1 (de) 2003-07-10 2005-02-17 Siemens Ag Kommunikationssystem, Peer-to-Peer-Nachrichten-Filter-Rechner und Verfahren zum Verarbeiten einer Peer-to-Peer-Nachricht
CA2608010A1 (en) 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
ES2416723T3 (es) 2007-10-09 2013-08-02 Merck Patent Gmbh Composiciones farmacéuticas que contienen benfotiamina y gabapentina
ES2619329T3 (es) 2007-11-23 2017-06-26 Grünenthal GmbH Composiciones de tapentadol
MX336979B (es) 2011-12-16 2016-02-09 Senosiain S A De C V Lab Combinacion farmaceutica antineuritica y composiciones.

Also Published As

Publication number Publication date
WO2016005897A1 (en) 2016-01-14
CO2017001076A2 (es) 2017-05-31
MX2014008336A (es) 2016-01-07
BR112017000359A2 (pt) 2018-06-26

Similar Documents

Publication Publication Date Title
CL2020002032A1 (es) Cristal de un compuesto derivado de 7,8-difluoro-6,11-dihidrodibenzotiepina, composición farmacéutica, útil en reducir el tiempo de alivio de los síntomas de la influenza para tratar y/o prevenir una infección provocada por el virus de la influenza. (divisional solicitud 201900325).
CL2018003588A1 (es) Uso de inhibidores de miostatina y terapias de combinación.
CL2017003138A1 (es) Compuesto derivado triciclico, metodo de preparacion del mismo y composicion farmaceutica que lo comprende.
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
NI201600051A (es) Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores
GT201700132A (es) Compuestos de isoxazol de ácido hidroxámico como inhibidores de lpxc
EA201692437A1 (ru) Комбинация
DOP2016000253A (es) Nuevos compuestos
EA201792496A1 (ru) Способы лечения воспаления или нейропатической боли
BR112022008294A2 (pt) Composições de profármaco e métodos de tratamento
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
ECSP19057403A (es) Usos terapéuticos de un polvo de insectos
CL2019002218A1 (es) Formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
BR112017003745A2 (pt) inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico
CL2019001746A1 (es) Amidas aromáticas de ácido carboxílico
MX2017012132A (es) Metodos y composiciones para inhibir los sintomas asociados con la veisalgia.
CO2017011778A2 (es) Un inhibidor de la actividad del csf-1r y composiciones farmaceuticas que lo comprenden
NI202000031A (es) Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3
PE20171140A1 (es) Combinacion farmacologica antihiperalgesica, antialodinica y antinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico
CR20160432A (es) Inhibidores de las vías de señalización de wnt
EA201691792A1 (ru) Фармацевтические составы на основе вилдаглиптина
UY36801A (es) PROCEDIMIENTO PARA EL TRATAMIENTO O LA PREVENCION DE CONDICIONES INMUNES RELACIONADAS CON INFECCIONES UTILIZANDO UNA COMPOSICION QUE COMPRENDE IgM
ECSP15050273A (es) Formulación oral para el tratamiento de enfermedades cardiovasculares
CL2017002229A1 (es) Inhibidores de bace1.
BR112019017314A2 (pt) composições farmacêuticas para terapia de combinação